MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Two Classes of Short Interfering RNA in RNA Silencing

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2002English

Therapeutic Gene Silencing Delivered by a Chemically Modified Small Interfering RNA Against Mutant SOD1 Slows Amyotrophic Lateral Sclerosis Progression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Short Interfering RNA Accumulation Correlates With Host Recovery in DNA Virus-Infected Hosts, and Gene Silencing Targets Specific Viral Sequences

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

Recognition of Small Interfering RNA by a Viral Suppressor of RNA Silencing

Nature
Multidisciplinary
2003English

Targeting Oncogenic Protein Kinase Cι for Treatment of Mutant KRAS LADC

Small GTPases
BiochemistryCell Biology
2016English

Allosteric Inhibitors Target KRAS in a Mutant-Specific Manner

Cancer Discovery
Oncology
2013English

Targeted, Systemic Delivery of Therapeutic Small Interfering RNA Nanoparticles

Science-Business eXchange
2009English

Secondary Small Interfering RNA-Based Silencing Tools in Plants: An Update

Frontiers in Plant Science
Plant Science
2019English

Mutant Kras Copy Number Defines Metabolic Reprogramming and Therapeutic Susceptibilities

Nature
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy